Merck has announced a € 59 million expansion of its HPAPI and ADC manufacturing capabilities and capacity at its facility…
Merck has announced a € 59 million expansion of its HPAPI and ADC manufacturing capabilities and capacity at its facility near Madison, Wisconsin, USA. This investment will allow large-scale manufacturing of increasingly potent compounds for therapies that have the potential to treat cancer. Completion is expected by mid-2022 and should…
International pharmaceutical company Novartis, already heavily invested in science and healthcare development partnerships across the continent, contributes around US$150 million…
International pharmaceutical company Novartis, already heavily invested in science and healthcare development partnerships across the continent, contributes around US$150 million to South African GDP each year, the company’s new CEO has revealed.
Visit the official COVID-19 government website to stay informed: sacoronavirus.co.za